News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,509 Results
Type
Article (19836)
Company Profile (142)
Press Release (310531)
Section
Business (105904)
Career Advice (882)
Deals (18616)
Drug Delivery (90)
Drug Development (50868)
Employer Resources (79)
FDA (7685)
Job Trends (7838)
News (186640)
Policy (17374)
Tag
Academia (751)
Alliances (27883)
Alzheimer's disease (570)
Approvals (7649)
Artificial intelligence (81)
Bankruptcy (170)
Best Places to Work (5618)
Biosimilars (68)
Biotechnology (64)
Cancer (550)
Cardiovascular disease (63)
Career advice (716)
Cell therapy (86)
Clinical research (41894)
Collaboration (216)
Compensation (69)
COVID-19 (1087)
C-suite (62)
Data (626)
Diabetes (95)
Diagnostics (1746)
Drug pricing (91)
Earnings (38547)
Employer resources (73)
Events (48062)
Executive appointments (201)
FDA (7946)
Funding (161)
Gene therapy (91)
GLP-1 (485)
Government (1822)
Healthcare (5957)
Infectious disease (1135)
Inflammatory bowel disease (67)
Interviews (116)
IPO (7347)
Job creations (2444)
Job search strategy (656)
Layoffs (255)
Legal (4095)
Lung cancer (98)
Manufacturing (129)
Medical device (2059)
Medtech (2062)
Mergers & acquisitions (11307)
Metabolic disorders (326)
Neuroscience (743)
NextGen Class of 2024 (2395)
Non-profit (931)
Northern California (670)
Obesity (209)
Opinion (177)
Patents (70)
People (33097)
Pharmaceutical (76)
Phase I (13039)
Phase II (17741)
Phase III (14284)
Pipeline (287)
Podcasts (56)
Policy (70)
Postmarket research (1622)
Preclinical (4599)
Radiopharmaceuticals (156)
Rare diseases (138)
Real estate (3186)
Regulatory (12169)
Research institute (838)
Resumes & cover letters (140)
Southern California (624)
Startups (2019)
United States (6169)
Vaccines (218)
Weight loss (183)
Date
Today (64)
Last 7 days (398)
Last 30 days (1884)
Last 365 days (18126)
2024 (16573)
2023 (19924)
2022 (26180)
2021 (26993)
2020 (25173)
2019 (20367)
2018 (15770)
2017 (17390)
2016 (16341)
2015 (18926)
2014 (14880)
2013 (12617)
2012 (13557)
2011 (13897)
2010 (12795)
Location
Africa (413)
Asia (24606)
Australia (3174)
California (1513)
Canada (746)
China (145)
Colorado (63)
Connecticut (61)
Europe (51174)
Florida (211)
Illinois (149)
Indiana (117)
Japan (56)
Maryland (239)
Massachusetts (1279)
Minnesota (88)
New Jersey (576)
New York (442)
North Carolina (358)
Northern California (670)
Ohio (65)
Pennsylvania (372)
South America (614)
Southern California (624)
Texas (194)
Washington State (145)
330,509 Results for "horizon pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
OKYO Pharma Limited announced an upcoming presentation of the OK-101 Phase 2 data for dry eye disease at the Dry Horizons Symposium, a partner meeting of the Association for Research in Vision and Ophthalmology, being held May 3, 2024 in Seattle, WA.
April 30, 2024
·
1 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Huntington’s
After Decades of Failure, First Disease-Modifying Huntington’s Treatment on the Horizon
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies including Prilenia and Wave Life Sciences eye paths to approval of therapies that could address the underlying cause of the disease.
November 11, 2024
·
7 min read
·
Heather McKenzie
Biotech Bay
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a panel on “Breast Cancer – Shifting an Entrenched Paradigm” at the 2024 CG Horizons in Oncology Virtual Conference on Monday, April 15, 2024, at 2:00 p.m. ET.
April 8, 2024
·
1 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Genetown
Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons
Ora, Inc. announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology 2024 conference, and as host and convener of the Dry Horizons Symposium in partnership with Ophthalmology Innovation Source.
May 1, 2024
·
5 min read
Press Releases
ONI Expands Horizons: Entering the Lipid Nanoparticle Research Market
September 17, 2024
·
2 min read
Biotech Bay
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer will participate in a panel at the Canaccord Genuity Horizons in Oncology Virtual Conference being held April 15, 2024.
April 8, 2024
·
1 min read
1 of 33,051
Next